Retrophin to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) — Retrophin, Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., chief executive […]
Ovid Therapeutics Receives FDA Rare Pediatric Disease Designation for OV101 for the Treatment of Angelman Syndrome
NEW YORK, June 19, 2020 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that […]
Nasdaq Pledges Continued Commitment to Diversity and Inclusion
Makes Donations to the Equal Justice Initiative and NAACPDebuts ‘Amplifying Black Voices’ Artist Series on Nasdaq MarketSite TowerLaunches Bell Ceremony […]
World’s First Gaming Browser, Opera GX, Adds Built-in Discord Support and Other Features in Major Birthday Release
OSLO, Norway, June 19, 2020 (GLOBE NEWSWIRE) — Opera GX, the world’s first gaming browser, is introducing new features including […]
uniQure Announces First Two Patients Treated in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
LEXINGTON, Mass. and AMSTERDAM, June 19, 2020 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing […]
36Kr Holdings Inc. Announces Changes to Board of Directors
BEIJING, June 19, 2020 (GLOBE NEWSWIRE) — 36Kr Holdings Inc. (“36Kr” or the “Company” or “We”) (NASDAQ: KRKR), a prominent […]
Luckin Coffee Received Notification from Mr. Tianruo Pu of his Resignation as an Independent Director
BEIJING, June 19, 2020 (GLOBE NEWSWIRE) — Luckin Coffee Inc. (the “Company”) (NASDAQ: LK) today announced the following:The Company received a […]
HOOKIPA Announces Changes to its Board of Directors – Resignation of Sander van Deventer
NEW YORK and VIENNA, Austria, June 19, 2020 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing […]
Obalon Announces First Quarter 2020 Financial Results and Business Update
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the […]
Immuron Partners with CSIRO to produce a new oral therapeutic for clinical evaluation by the US Department of Defense
Key PointsImmuron executes a Research Agreement with The Henry M. Jackson Foundation for Advancement of Military Medicine Inc.Immuron executes a […]
